Carisma Therapeutics
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Employees
- 107
- Market Cap
- $47.7M
- Introduction
Carmanah Minerals Corp is in the exploration stage company. It engages in the exploration and development of mineral properties in Canada. The projects in which the company holds an interest are Walker Project (Uranium), Hare Hill Project (Pluton), and Loljuh Project.
CAR-monocytes for the Treatment of HER2 Overexpressing Solid Tumors
Phase 1
Active, not recruiting
- Conditions
- HER2-positive
- Interventions
- Drug: CT-0525
- First Posted Date
- 2024-02-12
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- Carisma Therapeutics Inc
- Target Recruit Count
- 6
- Registration Number
- NCT06254807
- Locations
- 🇺🇸
University of Cincinnati, Cincinnati, Ohio, United States
CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors
Phase 1
Active, not recruiting
- Conditions
- HER2-positiveCarcinoma, HepatocellularLung Cancer, Non-Small-CellEsophagogastric Junction NeoplasmsInflammatory Breast CancerProstate CancerLung Cancer, Small CellBile Duct CancerCarcinoma, DuctalCancer
- Interventions
- Biological: CT-0508Biological: Pembrolizumab
- First Posted Date
- 2020-12-09
- Last Posted Date
- 2024-12-18
- Lead Sponsor
- Carisma Therapeutics Inc
- Target Recruit Count
- 48
- Registration Number
- NCT04660929
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
🇺🇸Abramson Cancer Center, Philadelphia, Pennsylvania, United States
🇺🇸Fred Hutchinson Cancer Center, Seattle, Washington, United States
© Copyright 2025. All Rights Reserved by MedPath